Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS
Key facts
- Where
- Kaunas, LithuaniaSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06278532, who can take part
Where in Lithuania
- Jonas MontvidasKaunas, LithuaniaTaking people
- Lithuanian University of Health Sciences Hospital Kaunas ClinicsKaunas, LithuaniaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Lithuanian University of Health Sciences
- Trial code
- NCT06278532
- Record updated
- 26 February 2024
- Original description
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.Read full original descriptionShow less
Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.
Inclusion: age 18 - 65 years old; Diagnosis of F20, F25 or F21 according to ICD-10; Signed informed consent form.
Exclusion: Patients with a comorbid or primary diagnosis of mental and behavioural disorders due to psychoactive substance use (F10 - F19); Patients with a comorbid of primary diagnosis of organic, including symptomatic, mental disorders (F00 - F09); Age younger than 18 or older than 65 years old; Did not sign the informed consent form; Legally inactive person; Patients with a comorbid or primary diagnosis of mental retardation according to ICD-10 (F70 - F79).